Replies to post #25271 on BioCurex, Inc.(fka BOCX)

[THE LURKER]

Thank you. I thought it looked too similar but I couldn't find anything to connect it to BioCurex. Are you certain that Abbott is out of this picture?

[THE LURKER]

I've just started looking into this company. It seems that there is still something in place with Abbott. This is from their FORM S-1/A - EX-10.4 - December 2, 2009

Read more: http://www.faqs.org/sec-filings/091202/BIOCUREX-INC_S-1.A/c58919_ex10-4.txt#ixzz0e4EZduHw


2.6 Other Licensees. Inverness is aware and understands that BioCurex has already signed an agreement with Abbott Labs (the "Abbot Labs Agreement") which (a) limits to three (3) the number of licensees for manufacturing RECAF tests to be used in the Field and (b) grants Abbott Labs the exclusive right to sublicense certain Licensed Materials and Technology. The licensing agreement with Abbott Labs includes the field of lateral flow chromatography (also known as rapid tests) on a non-exclusive basis, that is, the limitation in the number of licensees in the Field does not apply to lateral flow chromatography. If Abbott Labs ceases to be a BioCurex licensee, then, subject to the limitations in Section 0 below, BioCurex shall have the right to replace such licensee. In addition, if Abbott Labs ceases to be a BioCurex licensee, then it is understood that Abbott Labs will assign to BioCurex all of Abbott Labs' rights and obligations contained in each sublicense agreement between it and its sublicensees, provided that the applicable sublicensee provides its consent thereto